Ms. Linda Dale Korengold, OTR Occupational Therapist - Neurorehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1300 S South St, Globe, AZ 85501 Phone: 928-425-3118 |
Miss Connie Sung Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1100 E Monroe St, Globe, AZ 85501 Phone: 928-425-5721 |
News Archive
Pancreatic cancer is one of the most lethal forms of cancer because early stage symptoms are relatively light, often resulting in it being discovered only after spreading to other organs. In order to improve the prognosis of pancreatic cancer, the development of methods for early detection of pancreatic cancer with a blood test is important.
Xiaojun "Lance" Lian, assistant professor of biomedical engineering, was one of three recipients of the College of Engineering's ENGineering for Innovation & Entrepreneurship grant for "Small Molecule-Based Definitive Endoderm Kit and Pancreatic Progenitor Kit for Stem Cell Research and Therapy."
PAREXEL International Corporation a leading global biopharmaceutical services provider, and the National Taiwan University Hospital (NTUH) announced today that they have established an alliance. Under the agreement, PAREXEL and NTUH will collaborate to provide drug development services in Taiwan.
Leaders from Tufts Clinical and Translational Science Institute and Novartis announced today a new collaboration to work together to foster innovative translational research and improve health through the exchange of expertise, resources, and educational opportunities.
Neogenix Oncology announced today that the U.S. Patent and Trade Mark Office has issued a Notice of Allowance for a patent application related to its 16C3 antibody. Discovered and developed by Neogenix Oncology, this antibody appears to have anti-tumor activity for both pancreatic and colorectal tumors, and may have both therapeutic and diagnostic utility. The antibody may have activity in other tumors as well, which the company will explore at such time as it prepares a pre-IND package for FDA review and designs a clinical trial for the 16C3 antibody.
› Verified 3 days ago